How cells use a sugar process to build a strong immune system
The hexosamine biosynthesis pathway in metabolism and cell fate
This project explores how cells use a specific sugar process to build a strong immune system, which could lead to new ways to support your health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11174265 on NIH RePORTER |
What this research studies
Our bodies' cells make important decisions, like whether to grow or specialize, based on their genes, signals from other cells, and the nutrients available. This project aims to understand how cells process these different inputs, particularly focusing on how a sugar-related process called the hexosamine biosynthesis pathway influences cell decisions. We are specifically looking at how this pathway helps T cells, a type of immune cell, develop properly to create a strong defense against infections. By understanding how cells balance nutrient supply with their needs, we hope to find new ways to improve immune system function.
Who could benefit from this research
Good fit: Patients who might benefit in the future are those interested in understanding how nutrition can impact their immune health and potentially improve immune function.
Not a fit: Patients looking for immediate treatment options or direct clinical trials will not find direct benefit from this foundational laboratory research.
Why it matters
Potential benefit: If successful, this research could lead to new dietary strategies to enhance the immune system's ability to fight off diseases.
How similar studies have performed: This foundational work builds on existing knowledge about cell metabolism and immune function, exploring new connections that could lead to novel approaches.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Jacinto, Estela — Rutgers Biomedical and Health Sciences
- Study coordinator: Jacinto, Estela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.